Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
AI Could Reshape Clinical Trials-and the Business of Pharma
Welcome back to In the Loop, TIME's new twice-weekly newsletter about AI. If you're reading this in your browser, why not subscribe to have the next one delivered straight to your inbox? We hear a lot about how AI is accelerating drug discovery.
Karolinska Development's portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement
STOCKHOLM, Sweden, February 6, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has entered into a reverse acquisition agreement with Novakand Pharma. Throughout the agreement, Novakand will…
Fosun Pharma unit licenses lung cancer drug to Eisai in US$1.55 billion deal
A unit of Fosun Pharma has struck a US$1.55 billion deal to license its home-grown cancer drug to Japan's Eisai, adding to a wave of out-licensing agreements that are channelling billions of dollars into Chinese novel drug development. The deal…
Eye Care Firm SpyGlass Pharma Soars 50% After $150 Million IPO
SpyGlass Pharma Inc. shares jumped 50% in the biopharmaceutical firm's trading debut after it raised $150 million in an initial public offering. The company's shares traded at $24 each as of 12:12 p.m. in New York, above its IPO price of $16…
GLP-1 draws pharma advertisers to double down on the Super Bowl
This story is part of Digiday's annual coverage of the Super Bowl. More from the series → The Super Bowl offers a massive, if expensive, window of opportunity for advertisers looking to take advantage of its unrivaled audience reach –…
Thrivent Financial for Lutherans Trims Stake in Royalty Pharma PLC $RPRX
Thrivent Financial for Lutherans lowered its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 13.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 211,305 shares of the…
CII meet stresses safety culture in high-risk industries
The CII Andhra Pradesh Conference on Industrial Safety and Environmental Protection in High-Risk Factories held on Friday here aimed to strengthen safety and sustainability across chemical, pharmaceutical and other high-risk industries. The…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0815 GMT – Bayer released data for its asundexian drug candidate for stroke prevention that seem better…
Slate of Biotechs Heads to the Public Markets, Spurring Optimism
Biotechnology companies going public this week are signaling a resurgence for initial public offerings and venture-capital investment in the sector this year. Biotechs Eikon Therapeutics and Veradermics staged initial public offerings this week…
Long main street, short Wall Street': Why BofA says small stocks will keep beating bigger names
That's the message from Bank of America, which sees a 'major threat' to the market leadership of the early 2020s. The bank said investors should gravitate toward Main Street plays as the midterm elections approach. '[F]lip from asset-light to…
People have noticed that TrumpRX looks a lot like GoodRX. There's a reason for the similarities
President Trump and the Republican party have worked hard over the years to undermine the Affordable Care Act (ACA), leaving fewer people with access to health insurance. Now, the current administration is launching TrumpRx, a site that offers…
Gas leak at Vapi factory, 4 hospitalised
2 min read Surat Make us preferred source on Google At least four persons were hospitalised following a gas leak at a factory near Vapi in Valsad on Friday, Gujarat Pollution Control Board (GPCB) officials said. The incident was reported from Sinex…
Pfizer Hympavzi label expansion under FDA review (PFE:NYSE)
Pfizer (PFE) announced on Friday that the U.S. Food and Drug Administration granted priority review for a marketing application seeking a label expansion for its hemophilia therapy, Hympavzi. The New York-based pharma giant had submitted its…
Why economists see the housing market flattening in 2026
Getting your Trinity Audio player ready... Economists I polled this week had some interesting opinions about the housing market, the broader economy and President Donald Trump. Mark Vitner, chief economist at Piedmont Crescent Capital, explained…
2026 Outlook: Afrezza, Furoscix, And MannKind's Path To Revenue Expansion (NASDAQ:MNKD)
MannKind Corporation is transitioning from a volatile biotech to a diversified, revenue-driven pharma, with FUROSCIX and Afrezza driving commercial momentum. MNKD's 2026 business outlook highlights expanding commercial assets, key regulatory…
Receive a Daily briefing on Pharma Industry News
Get Started